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ABSTRACT
Infective endocarditis (IE) often develops into rheumatic heart disease 
(RHD) that has many perioperative complications during the evolution of 
the disease. Cardiac surgery in patients with IE is often followed by post-
operative morbidities that can decrease the quality of life. This study aimed 
to investigate the correlations between preoperative IE and the emergence 
of various morbidities in patients undergoing heart valve surgery. This was 
a cross-sectional study with secondary data analysis of the medical record 
in 60 patients with mitral valve surgery at Dr. Sardjito General Hospital, 
Yogyakarta from 2012 to 2017. As much as 30 of 60 patients were suffered IE 
before mitral valve surgery. The most common valve disease in the IE group 
was mitral stenosis (60%). IE was significantly associated with arrhythmia and 
cardiac event with p=0.002 (PR: 6.91), prolonged ICU stay with p=0.011 (PR: 
5.68), prolonged ventilator use with p=0.015 (PR: 12.43) and severe pulmonary 
arterial hypertension (PAH) with p=0.033 (PR: 0.192) post mitral valve surgery. 
As many as 26 (87%) and 29 (96.7%) of patients with IE had a prolonged ICU stay 
and prolonged ventilator after mitral valve surgery respectively. The incidence 
of severe PAH postoperatively in the IE group was lower than in the non-IE 
group (10% vs 36.7%). IE was significantly associated with the increased risk 
of arrhythmia, prolonged ventilator use and prolonged ICU stay after mitral 
valve surgery. 
ABSTRAK
Infective endocarditis (IE) sering berkembang menjadi penyakit jantung 
rematik (PJR) yang memiliki banyak komplikasi perioperatif selama evolusi 
penyakit. Operasi jantung pada pasien dengan IE sering diikuti oleh morbiditas 
pasca operasi yang dapat menurunkan kualitas hidup. Penelitian ini bertujuan 
untuk menyelidiki korelasi antara IE sebelum operasi dan munculnya berbagai 
morbiditas pada pasien yang menjalani operasi katup jantung. Penelitian ini 
merupakan penelitian cross-sectional dengan analisis data sekunder dari 
rekam medis pada 60 pasien dengan operasi katup mitral di Rumah Sakit Umum 
Dr. Sardjito, Yogyakarta tahun 2012 hingga 2017. Sebanyak 30 dari 60 pasien 
menderita IE sebelum operasi katup mitral. Penyakit katup yang paling umum 
pada kelompok IE adalah stenosis mitral (60%). IE secara bermakna dikaitkan 
dengan aritmia dan cardiac event dengan p=0,002 (PR: 6,91), lama tinggal di 
ICU dengan p=0,011 (PR: 5,68), penggunaan ventilator berkepanjangan dengan 
p=0,015 (PR: 12,43) dan pulmonary arterial hypertension (PAH ) dengan p=0,033 
(PR: 0,192) pasca operasi katup mitral. Sebanyak 26 (87%) dan 29 (96,7%) 
dari pasien dengan IE memiliki lama tinggal di ICU dan ventilator yang lama 
setelah operasi masing-masing katup mitral. Insiden PAH parah pasca operasi 
pada kelompok IE lebih rendah daripada kelompok non-IE (10% vs 36,7%). IE 
secara signifikan dikaitkan dengan peningkatan risiko aritmia, penggunaan 
ventilator berkepanjangan dan tinggal ICU berkepanjangan setelah operasi 
katup mitral.
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INTRODUCTION
Infective endocarditis (IE) can cause 
life-threatening conditions and still 
has a high mortality rate.1,2 IE is often 
accompanied by cardiac complications, 
the incidence of embolism, and related 
to prolonged hospitalization in an 
intensive care unit (ICU).2,3 Long-term 
IE often develops into rheumatic heart 
disease (RHD) which usually manifests 
as damage of the heart valves.4 Clinical 
management of heart valve disease 
depends on clinical presentation and 
surgical treatment is an intervention 
that can change the progression of 
valve disease.4 Surgery provides the 
potential for life-saving interventions 
to remove infected tissue and any 
source of embolism.1,5 Although surgical 
procedures are often needed, they are 
associated with increased postoperative 
morbidity and mortality.6
Many complications occur during 
the evolution of IE,7 and a variety of the 
causative microorganisms can create a 
wide variety of complications.3 Patients 
undergoing cardiac surgery with 
perioperative complications require 
long ICU stays and this condition is 
usually associated with high mortality 
and morbidity after discharge from the 
hospital.8 Most of the IE cases will require 
treatment in the ICU. But unfortunately, 
there are still few studies that focus 
on patients with IE and the multiple 
complications leading to ICU admission.7 
For this reason, this study was 
investigated to see any correlations 
between preoperative IE and the 
emergence of various morbidities in 
patients undergoing heart valve surgery. 
MATERIALS AND METHODS
This study was a cross-sectional 
study and conducted at Dr. Sardjito 
General Hospital, Yogyakarta, Indonesia, 
on patients who underwent mitral valve 
surgery. Secondary data were collected 
from medical records from January 
2012-December 2017 relating to the 
following inclusion criteria: all patients 
with primary mitral valve surgery. 
Informed consent was taken from all 
patients before the procedure was 
conducted.
The exclusion criteria were as follows: 
1) missing data about the variables in the 
medical record; 2) diabetic patient with 
a glucose level >200mmHg; 3) patient 
with renal failure before surgery and 
4) patient with a prior history of heart 
surgery. This study was approved by 
The Medical and Health Research Ethics 
Committee (MHREC) from Faculty of 
Medicine, Public Health and Nursing, 
Universitas Gadjah Mada, Yogyakarta, 
Indonesia (KE/FK/0692/EC/2017).
Diagnosis of IE that was taken 
and made by cardiologist according 
to modified Duke University criteria,9 
and then pharmacologically treated by 
cardiologist according to service protocol 
of IE in Dr. Sardjito General Hospital, 
Yogyakarta. Surgical intervention by a 
cardiac surgeon was indicated when 
there was the condition of heart failure, 
uncontrolled infection or to prevent the 
thromboembolism event.5,9 Mitral valve 
was chosen because among all heart 
valves, mitral valve was most frequent 
site of vegetation related IE, and followed 
by aortic valve.10 Surgical data and the 
morbidities after surgery were collected 
from medical record. 
We defined postoperative cardiac 
morbidities by all of the cardiac 
problems that appear after surgery such 
as pulmonary arterial hypertension, 
any arrhythmia, and cardiac events. 
We included all types of arrhythmias as 
one of the cardiac abnormalities which 
is a diagnosis from the Cardiologist. 
ICU admission was assessed by SOFA 
score7 and prolonged stay in ICU was 
defined if patients stay more than 6 
days in the ICU after the surgery. We 
defined postoperative stroke based 
on the Stroke Council of the American 
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Heart Association/American Stroke 
Association.11 Acute renal failure was 
defined by Kidney Disease Improving 
Global Outcome (KDIGO) criteria.12 
Pulmonary arterial hypertension was 
defined by pulmonary arterial systolic 
pressure (PASP) above 25 mmHg, 
and categorized as severe pulmonary 
arterial hypertension when PASP >55 
mmHg.13 Mortality as major morbidity 
was defined as death directly related 
to surgery or post-surgery care, both 
related to cardiac and other problems. 
Baseline characteristics of data 
between IE and non-IE groups were 
presented in tabular form. Comparisons 
to evaluate significant differences 
between IE and non-IE groups were 
conducted using chi-square or Fisher’s 
exact test. Variables considered 
significantly different if the value 
was p<0.05. Statistical analysis was 
performed using SPSS Statistics version 
23 (IBM, Chicago).
RESULTS
Characteristics data of the patients 
are shown in TABLE 1. A total of 60 patients 
who underwent mitral valve surgery 
were included in the study from whom 
30 (50%) had IE determined by fulfilling 
the modified Duke criteria. Most of the 
subjects were female, making up 63.3% 
of the IE patients. The average age of the 
subject was 38.07±10.7 years, with the 
oldest age was 58 years and the youngest 
was 18 years. The majority of the heart 
valve abnormalities in IE patients were 
mitral stenosis 18 (60%) with mitral valve 
replacement as the most performed 
procedures in the IE group (56,7%). There 
were some postoperative morbidities in 
IE patients that were recorded, such as 
arrhythmia and cardiac event (63.3%), 
stroke (16.7%), prolonged ICU stay 
(86.7%), acute renal failure (30%), severe 
PAH (10.0%), prolonged ventilator use 
(96.7%) and mortality (16.7%). 
TABLE 1. Baseline Characteristics of Patients
Variables IE n (%) Non-IE n (%)
Sex
•	 Male 11 (36.7) 7 (23.3)
•	 Female 19 (63.3) 23 (76.7)
Age (years old)
•	 ≤ 20 2 (6.7) 1 (3.3)
•	 21-30 10 (33.3) 3 (10.0)
•	 31-40 8 (26.7) 11 (36.7)
•	 41-50 7 (23.3) 11 (36.7)
•	 > 51 3 (10.0) 4 (13.3)
Procedure
•	 Mitral valve repair 8 (26.7) 9 (30.0)
•	 Double valve repair 5 (16.7) 0 (0.0)
•	 Mitral valve replacement 17 (56.7) 10 (33.3)
•	 Double valve replacement 0 (0.00) 11 (36.7)
Mitral valve disorder
•	 Mitral stenosis 18 (60.0) 13 (43.3)
•	 Mitral regurgitation 8 (26.7) 6 (20.0)
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•	 Mitral stenosis + regurgitation 4 (13.3) 11 (36.7)
Pulmonary hypertension
•	 Severe (>55 mmHg) 3 (10.0) 11 (63.3)
•	 Mild to moderate (25-54 mmHg) 27 (90.0) 19 (36.7)
Postoperative morbidities
•	 Arrythmia and cardiac event 19 (63.3) 6 (20.0)
•	 Prolonged ventilator use 29 (96.7) 21 (70.0)
•	 Severe PAH 3 (10.0) 11 (36.7)
•	 Stroke 5 (16.7) 3 (10.0)
•	 Prolonged ICU stay 26 (86.7) 16 (53.3)
•	 Acute renal failure 9 (30.0) 7 (23.3)
•	 Mortality 5 (16.7) 6 (20.0)
Noted: intensive care unit (ICU); pulmonary arterial hypertension (PAH)
Significant differences between IE 
and non-IE groups toward morbidities 
are shown in TABLE 2. Postoperative 
arrhythmia and cardiac event, prolonged 
ventilator use, prolonged ICU stay 
and severe PAH showed a significant 
difference with the  p-value=0.002, 
p=0.015, p=0.011 and p=0.033, 
respectively. In our study, the IE group 
had an almost 7-fold higher risk to have 
any arrhythmia and cardiac event and 
also had risk to prolonged ventilator use 
up to more than 12-fold higher than the 
non-IE group after mitral valve surgery. 
Furthermore, the risk of prolonged ICU 
stay increased up to 5-fold higher in 
patients who had IE before surgery. On 
the other hand, the risk of severe PAH 
after mitral valve surgery decreased in 
the IE group. While the others morbidities 
such as stroke, acute renal failure and 
mortality after mitral valve surgery 
did not show a significant difference 
between IE and non-IE groups.
TABLE 2. Morbidities after mitral valve surgery
Postoperative morbidities p PR (95% CI)
Arrythmia and cardiac event 0.002* 6.909 (2.160 – 22.098)
Prolonged ventilator use 0.015* 12.429 (1.461-105.737)
Severe PAH 0.033* 0.192 (0.047 – 0.782)
Stroke 0.771 1.408 (0.445 – 4.453)
Prolonged ICU stay 0.011* 5.688 (1.591 – 20.330)
Acute renal failure 0.386 1.286 (0.551 – 3.003)
Mortality 1.000 0.800 (0.215 -2.972)
Noted: * significant difference; confidence interval (CI); intensive care unit 
(ICU); pulmonary arterial hypertension (PAH); Infective endocarditis 
(IE);    prevalence ratio (PR)
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DISCUSSION
Despite progress in the diagnosis 
and management of IE, the morbidity 
and mortality after heart valve surgery 
still frequently appear.1,10,11 In our study, 
our patients were mostly female, and 
this result is the same as Rusingiza et 
al.14 and Russell et al.15 reported that IE 
patients who underwent mitral valve 
surgery was predominantly female, and 
composed of children and young adults. 
IE often develops into RHD with the 
predominant site affected is the mitral 
valve, and followed by aortic valve.2,10,16 
Mitral stenosis is likely to reflect the 
more advanced IE condition related 
mitral valve disease.15 Our study showed 
that mitral valve stenosis was most 
common mitral valve abnormalities in 
both IE and non-IE groups. The most 
common mitral valve surgery procedure 
that was performed in our study was 
mitral valve replacement (MVR). Russell 
et al.15 showed mitral valve replacement 
procedure is mostly done in IE groups, 
there was no difference in adjusted 
short-term or long-term survival after 
surgery.
Our study showed that IE patients 
had 5-fold higher risk to experience a 
prolonged ICU stay more than 6 days 
which occurred in 86.6% of IE patients. 
Pato et al.4 and Farag et al.17 also showed 
that IE patients who underwent mitral 
valve surgery have an increased risk of 
prolonged stay in the ICU with an average 
treatment period more than 10 days. 
Another study with larger samples also 
showed similar results with an average 
length of stay in the ICU of almost 8 
days, and it related to the advanced 
classifications of the New York Heart 
Association (NYHA III or NYHA IV) before 
surgery and is usually associated with 
poor prognosis. Additionally, another 
consequence of the longer stay in the 
ICU is the increase of the cost involved.18 
The prolonged ICU stay is also related to 
sepsis that can potentially appear in IE 
patients and usually has worse survival 
rates.19 Patients who underwent heart 
valve surgery and prolonged ICU stay 
have further indicated a lower quality of 
life.8 
The incidence of postoperative 
prolonged ventilators increased in 
the IE group. In our study, patients 
with IE were 12-fold risk to experience 
prolonged ventilators after mitral valve 
surgery. Russell et al. reported that the 
duration of ventilation in the IE group 
was longer than the non-IE group, and 
patients with replacement surgery had a 
longer period of ventilation and in ICU.15 
Both replacement and repair surgery 
in mitral valve are effective for MV 
disease.20 Although there is superiority 
of MV repair over MV replacement 
for degenerative valve, patients with 
rheumatic disease because of IE may 
reduce the durability of MV repair.20 
The increase of pulmonary artery 
pressure often occurs in both mitral 
stenosis and mitral regurgitation, and 
the presence of pulmonary arterial 
hypertension (PAH) in mitral valve 
disease is also key to determine the best 
treatment.21,22 PAH can be occurred due 
to an increase in left atrial pressure 
which can be developed into pulmonary 
venous hypertension and subsequent 
pulmonary arterial hypertension. IE that 
has developed into mitral valve disease 
will increase the risk of PAH, and the 
risk can be reduced by eliminating the 
disease in the mitral valve.21 Our study 
showed the same result that the increase 
in pulmonary arterial pressure after 
mitral valve surgery was lower in the IE 
group, because the source of the mitral 
valve disease has been removed by 
surgery procedure. 
Cardiac morbidity after heart valve 
surgery is significantly associated 
with IE,2,4 while the surgery also 
increases the risk of arrhythmia such 
as heart block, atrial and ventricular 
tachyarrhythmias.1,23,24 Arrhythmias 
are very common complications of 
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open-heart surgery such as mitral 
valve surgery, and become the major 
source of other morbidity.23 Structural 
damage due to heart disease such as 
heart valve damage increased the risk of 
arrhythmia, even the trauma due to the 
surgery itself predispose for atrial and 
ventricular arrhythmias.23,24 In addition, 
structural damage is often accompanied 
by hemodynamic changes in complicated 
IE and this condition triggers an early 
atrial arrhythmia postoperatively.24 
Atrioventricular block occurred in 
16.6% post-cardiac surgery patients 
with IE.17 Another study found that 
patients with preoperative low ejection 
fraction are a higher risk of experiencing 
postoperative ventricular arrhythmia.25 
Acute coronary syndrome can also 
be a complication of IE due to septic 
embolism.26 These findings support our 
study which showed that IE patients had 
a 7-fold higher risk of cardiac morbidity 
after mitral valve surgery. 
Neurological complications are the 
most common extracardiac complications 
of IE patients, with incidence of embolic 
stroke in approximately 25% to 30% 
of the mitral valve IE.27 Staphylococcus 
aureus-associated IE had a higher risk 
of stroke and systemic embolization.26 
Our findings show that stroke appeared 
in 16.7% of IE patients who underwent 
mitral valve surgery although considered 
not statistically significant. Furthermore, 
cardiac surgery in IE patients with 
stroke before surgery can potentially 
worsen neurological symptoms due to 
complications from cerebral hemorrhage 
related to heparinization and the 
expansion of ischemic stroke related to 
hypotension during cardiopulmonary by 
past.28
Acute renal failure can occur in 
about 30% of patients who underwent 
cardiac surgery, especially in heart 
failure, diabetes mellitus, and geriatric 
patients and associated with 30-days 
mortality post-cardiac surgery.12,17 Our 
findings showed that acute renal failure 
appeared in 30% of IE patients although 
not considered statistically significant 
due to the small sample population. 
In a larger study, renal insufficiency 
increased mortality 1.6-fold higher in IE 
patients, although postoperative renal 
failure complications appeared in only 
7.2% of subjects and average care in the 
ICU for more than 7 days.29 
There were several limitations in 
this study. First, the subjects were not 
randomized. Second, we only took the 
data from the patients’ medical records. 
This study only observed in patients 
who underwent mitral valve surgery 
without identifying the pharmacological 
therapies that had been given and 
the causative bacteria of the IE. 
Besides that, the determination of the 
relationship between preoperative IE 
and postoperative morbidity is difficult 
to determine precisely because of the 
wide variety of factors that affect the 
condition of the patients.
CONCLUSION
IE was significantly associated 
with the increased risk of arrhythmia, 
prolonged ventilator use and prolonged 
ICU stay after mitral valve surgery. To 
confirm our findings, a multicenter 
study with a larger sample of patients is 
necessary.
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